Dureach

Alpha-9 Oncology

Canada
NameAddress
Sydney Forks, Nova Scotia, Canada
778-231-2500 ★
https://www.a9oncology.com

Company profile

Alpha-9 Oncology company profile

Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

Business identity

Website
https://www.a9oncology.com
Contact email
[email protected]
Phone number
778-231-2500
Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Founded
2019-01-01
LinkedIn

Headquarters

Headquarters
Sydney Forks, Nova Scotia, Canada
Postal code
V7X 1L3
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
4
Total equity funding
$259M
Last funding
Series C / $175M / 2024-10-23
Last equity funding
Series C / $175M
Investors
17
Lead investors
4
Founders
1
Articles
11

Categories and groups

BiotechnologyMedicalProduct ResearchBiotechnologyData and AnalyticsDesignHealth CareScience and Engineering

Founders and investors

Founders

David Perrin

Lead investors

Ascenta CapitalLightspeed Venture PartnersLongitude CapitalNextech Invest

Investors

Andreessen HorowitzGeneral CatalystJanus Henderson InvestorsLightspeed Venture PartnersRA Capital Management

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.